2026-01-27 - Analysis Report
**Lam Research (LRCX) Report**
=====================================

### Overview

Lam Research is a semiconductor equipment supplier company that provides advanced wafer fabrication equipment to the global semiconductor industry.

### Performance Comparison
--------------------------------

| **Metric** | **LRCX (Rate)** | **S&P 500 (VOO) (Rate vs)** |
| --- | --- | --- |
| Cumulative Return | 885.30% | 127.58% |
| Divergence | 737.10 | N/A |

The cumulative return of Lam Research is significantly higher than that of the S&P 500, indicating a higher degree of divergence.

### Alpha, Beta Analysis
-------------------------

| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap (B)** |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 14.0% | 33.7% | 5.0% | 1.6 | 17.2B |
| 2017-2019 | 89.0% | 33.7% | 64.0% | 1.7 | 36.9B |
| 2018-2020 | 147.0% | 44.4% | 123.0% | 1.5 | 59.5B |
| 2019-2021 | 293.0% | 44.4% | 229.0% | 1.6 | 90.7B |
| 2020-2022 | 2.0% | 54.3% | -3.0% | 1.6 | 53.0B |
| 2021-2023 | 65.0% | 54.3% | 47.0% | 1.8 | 98.8B |
| 2022-2024 | -11.0% | 45.7% | -41.0% | 1.9 | 91.1B |
| 2023-2025 | 482.0% | 46.1% | 406.0% | 2.0 | 215.9B |

### Recent Stock Price Fluctuations
---------------------------------

| **Metric** | **Value** |
| --- | --- |
| Close | $222.87 |
| 5-day SMA | $222.46 |
| 20-day SMA | $205.22 |
| 60-day SMA | $174.54 |

The stock price is currently near its 5-day SMA, indicating a possible consolidation period.

### RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence
----------------------------------------------------------

| **Metric** | **Value** |
| --- | --- |
| MRI | 0.70 |
| RSI | 66.47 |
| PPO | -0.24 |
| Expected Return (%) | 52.00% |

The risk level is currently set to Medium, with the MRI at 0.70. The RSI is above 60, indicating a possible trend continuation, while the PPO is below 0, indicating a possible downtrend.

### Recent News & Significant Events
--------------------------------------

* Lam Research stock jumps near 3% as Evercore lifts target â€” what LRCX investors watch next
* Lam Research Sits At Heart Of AI Chip And CHIPS Act Cycle
* LRCX Outperformed in 2025, but Valuation and Options Activity Flag 2026 Risks
* Lam Research (NASDAQ:LRCX) Trading 2.3% Higher Following Analyst Upgrade
* LRCX Likely to Beat Q2 Earnings Estimates: Should You Buy the Stock?
* AI-Driven Foundry Demand Likely to Boost LRCX's Systems Revenues in Q2

### Analyst Opinions
-------------------

Analyst Consensus:

* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
* Opinions: 31
* Target Price (avg/high/low): $215.35 / $265.00 / $115.00

### Recent Earnings Analysis
-----------------------------

| **Date** | **EPS** | **Revenue** |
| --- | --- | --- |
| 2025-10-24 | $1.24 | $5.32 B$ |
| 2025-04-25 | $1.04 | $4.72 B$ |
| 2025-01-31 | $0.93 | $4.38 B$ |
| 2024-10-28 | $0.86 | $4.17 B$ |
| 2025-10-24 | $0.86 | $4.17 B$ |

The company has consistently reported a revenue increase over the past few quarters, with a slight decline in EPS in Q2 2025.

### Financial Information (Revenue and Profitability)
---------------------------------------------------------

| **Quarter** | **Revenue** | **Profit Margin** |
| --- | --- | --- |
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

The revenue has increased steadily over the past three quarters, with a slight decline in profit margin.

### Financial Information (Capital and Profitability)
-------------------------------------------------------

| **Quarter** | **Equity** | **ROE** |
| --- | --- | --- |
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

The equity has increased steadily over the past three quarters, with a slight decline in ROE.

### Comprehensive Analysis (Summary of previous items)
-------------------------------------------------------

Lam Research has consistently reported a revenue increase over the past few quarters, with a slight decline in EPS in Q2 2025. The stock price is currently near its 5-day SMA, indicating a possible consolidation period. The risk level is currently set to Medium, with the MRI at 0.70. The RSI is above 60, indicating a possible trend continuation, while the PPO is below 0, indicating a possible downtrend. Analyst consensus is Buy, with a target price range of $215.35 - $265.00.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.